Innospec (IOSP) EBITDA (2010 - 2026)

Innospec has disclosed EBITDA across 17 years of filings, most recently posting $39.7 million for Q2 2026.

• In Q2 2026, EBITDA rose 15.74% year-over-year to $39.7 million; the TTM figure through Jun 2026 stood at $128.9 million (down 21.16% YoY), while the FY2025 annual figure was $129.5 million, down 27.21% from the prior year.
• EBITDA came in at $39.7 million for Q2 2026 at Innospec, up from $36.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $50.5 million in Q1 2024 to a low of $5.9 million in Q3 2025.
• Average EBITDA over 5 years is $40.7 million, with a median of $42.2 million recorded in 2023.
• Year-over-year, EBITDA surged 59.55% in 2022 and sank 87.06% in 2025.
• Over 5 years, EBITDA stood at $46.6 million in 2022, then retreated by 4.51% to $44.5 million in 2023, then fell by 7.64% to $41.1 million in 2024, then advanced by 13.87% to $46.8 million in 2025, then declined by 15.17% to $39.7 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $39.7 million in Q2 2026, $36.5 million in Q1 2026, and $46.8 million in Q4 2025.